Literature DB >> 26626229

Autoimmune epilepsy.

Antonio Greco1, Maria Ida Rizzo2, Armando De Virgilio3, Michela Conte1, Andrea Gallo4, Giuseppe Attanasio1, Giovanni Ruoppolo1, Marco de Vincentiis1.   

Abstract

Despite the fact that epilepsy is the third most common chronic brain disorder, relatively little is known about the processes leading to the generation of seizures. Accumulating data support an autoimmune basis in patients with antiepileptic drug-resistant seizures. Besides, recent studies show that epilepsy and autoimmune disease frequently co-occur. Autoimmune epilepsy is increasingly recognized in the spectrum of neurological disorders characterized by detection of neural autoantibodies in serum or spinal fluid and responsiveness to immunotherapy. An autoimmune cause is suspected based on frequent or medically intractable seizures and the presence of at least one neural antibody, inflammatory changes indicated in serum or spinal fluid or on MRI, or a personal or family history of autoimmunity. It is essential that an autoimmune etiology be considered in the initial differential diagnosis of new onset epilepsy, because early immunotherapy assures an optimal outcome for the patient.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune disease; Autoimmune epilepsy; Autoimmune seizures; Epilepsy; Refractory epilepsy

Mesh:

Substances:

Year:  2015        PMID: 26626229     DOI: 10.1016/j.autrev.2015.11.007

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  9 in total

1.  Scratching the Surface in Autoimmune Epilepsy: It is the Time to Dig Deeper, But How?

Authors:  Adriana Bermeo-Ovalle
Journal:  Epilepsy Curr       Date:  2017 Jul-Aug       Impact factor: 7.500

Review 2.  Protein biomarkers of epileptogenicity after traumatic brain injury.

Authors:  Denes V Agoston; Alaa Kamnaksh
Journal:  Neurobiol Dis       Date:  2018-07-17       Impact factor: 5.996

3.  Parental rheumatoid arthritis and childhood epilepsy: A nationwide cohort study.

Authors:  Ane Lilleøre Rom; Chun Sen Wu; Jørn Olsen; Damini Jawaheer; Merete Lund Hetland; Jakob Christensen; Bent Ottesen; Lina Steinrud Mørch
Journal:  Neurology       Date:  2016-11-16       Impact factor: 9.910

4.  Genetic or Autoimmune: POLG-Related Epilepsy Initially Treated as an Autoimmune Encephalitis, a Case Report.

Authors:  Suma Shah; Abigail Berezoski; Shareena Rahman; Christopher Eckstein; Matthew Luedke
Journal:  Neurohospitalist       Date:  2020-08-25

5.  An Overview of The Role of Tumor Necrosis Factor-Alpha in Epileptogenesis and Its Terapeutic Implications.

Authors:  Alexandre Michev; Alessandro Orsini; Viola Santi; Francesco Bassanese; Daniele Veraldi; Ilaria Brambilla; Gian Luigi Marseglia; Salvatore Savasta; Thomas Foiadelli
Journal:  Acta Biomed       Date:  2022-03-21

6.  Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications.

Authors:  Giorgio Costagliola; Greta Depietri; Alexandre Michev; Antonella Riva; Thomas Foiadelli; Salvatore Savasta; Alice Bonuccelli; Diego Peroni; Rita Consolini; Gian Luigi Marseglia; Alessandro Orsini; Pasquale Striano
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

7.  GluR3B Antibody Was a Biomarker for Drug-Resistant Epilepsy in Patients With Focal to Bilateral Tonic-Clonic Seizures.

Authors:  Qingwei Lai; Qingyun Li; Xinyu Li; Heng Wang; Wei Zhang; Xiaotao Song; Peng Hu; Ruiqin Yao; Hongbin Fan; Xingshun Xu
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

8.  GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Authors:  Suvi Liimatainen; Jerome Honnorat; Sean J Pittock; Andrew McKeon; Mario Manto; Jared R Radtke; Christiane S Hampe
Journal:  Orphanet J Rare Dis       Date:  2018-04-10       Impact factor: 4.123

Review 9.  Anti-Hu-related epilepsy diagnosed after surgical management.

Authors:  Yongsu Zheng; Nian Wei; Jian Wang; Hui Dai; Zucai Xu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.